Uveitis Active Not Recruiting Phase 3 Trials for Baricitinib (DB11817)

Also known as: Unspecified iridocyclitis / Uveitis NOS / Uveitis (disorder)

IndicationStatusPhase
DBCOND0009937 (Uveitis)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04088409A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive UveitisTreatment